The Food and Drug Administration approved a rapid coronavirus test on Saturday that will deliver results in about 45 minutes. The test will be available in the next few weeks and no training will be necessary to administer the tests.
The new test will begin shipping next week, according to Cepheid, the company behind the rapid molecular diagnostic test for qualitative detection of SARS-CoV-2.
"Cepheid currently has nearly 5,000 GeneXpert® Systems in the US capable of point-of-care testing and for use in hospitals," said Cepheid President Warren Kocmond. "Our automated systems do not require users to have specialty training to perform testing — they are capable of running 24/7, with many systems already doing so today."
Cepheid's Chief Medical Officer, Dr. David Persing, discusses Cepheid's new diagnostic test for qualitative detection of SARS-CoV-2, the virus causing COVID-19. Watch below.
A Covid-19 test can deliver results in less than an hour has been approved under an FDA emergency authorization, marking the first test that clinicians can use at the bedside https://t.co/2NXrygR32H— Bloomberg (@business) March 21, 2020
A rapid test to detect the coronavirus, developed by Cepheid -- a Sunnyvale company, has been given “emergency use authorization” by Food and Drug Administration, officials said Saturday. https://t.co/mLeMPf639G— KPIX 5 (@KPIXtv) March 21, 2020